Daniel Alexander Yerace - Net Worth and Insider Trading
Daniel Alexander Yerace Net Worth
The estimated net worth of Daniel Alexander Yerace is at least $380,688 dollars as of 2024-05-16. Daniel Alexander Yerace is the VP of Operations of Coeptis Therapeutics Holdings Inc and owns about 1,071,455 shares of Coeptis Therapeutics Holdings Inc (COEP) stock worth over $380,688. Details can be seen in Daniel Alexander Yerace's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Alexander Yerace has not made any transactions after 2024-01-05 and currently still holds the listed stock(s).
Transaction Summary of Daniel Alexander Yerace
Daniel Alexander Yerace Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Alexander Yerace owns 1 companies in total, including Coeptis Therapeutics Holdings Inc (COEP) .
Click here to see the complete history of Daniel Alexander Yerace’s form 4 insider trades.
Insider Ownership Summary of Daniel Alexander Yerace
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings Inc | 2024-01-05 | director & VP of Operations |
Daniel Alexander Yerace Latest Holdings Summary
Daniel Alexander Yerace currently owns a total of 1 stock. Daniel Alexander Yerace owns 1,071,455 shares of Coeptis Therapeutics Holdings Inc (COEP) as of January 5, 2024, with a value of $380,688.
Latest Holdings of Daniel Alexander Yerace
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings Inc | 2024-01-05 | 1,071,455 | 0.36 | 380,688 |
Holding Weightings of Daniel Alexander Yerace
Daniel Alexander Yerace Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Alexander Yerace has made a total of 1 transactions in Coeptis Therapeutics Holdings Inc (COEP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coeptis Therapeutics Holdings Inc is the acquisition of 10,850 shares on January 5, 2024, which cost Daniel Alexander Yerace around $7,487.
Insider Trading History of Daniel Alexander Yerace
- 1
Daniel Alexander Yerace Trading Performance
GuruFocus tracks the stock performance after each of Daniel Alexander Yerace's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Alexander Yerace is -53.28%. GuruFocus also compares Daniel Alexander Yerace's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Alexander Yerace within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Alexander Yerace's insider trading performs compared to the benchmark.
Performance of Daniel Alexander Yerace
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.72 |  | | | | |
| Relative Return to S&P 500(%) | -27.95 | | | | | |
Daniel Alexander Yerace Ownership Network
Daniel Alexander Yerace Owned Company Details
What does Coeptis Therapeutics Holdings Inc do?
Who are the key executives at Coeptis Therapeutics Holdings Inc?
Daniel Alexander Yerace is the director & VP of Operations of Coeptis Therapeutics Holdings Inc. Other key executives at Coeptis Therapeutics Holdings Inc include director & 10 percent owner & CEO and President David Mehalick , director & 10 percent owner & Chief Financial Officer Chris Calise , and CFO and Secretary Christine Elise Sheehy .
Coeptis Therapeutics Holdings Inc (COEP) Insider Trades Summary
Over the past 18 months, Daniel Alexander Yerace made 1 insider transaction in Coeptis Therapeutics Holdings Inc (COEP) with a net purchase of 10,850. Other recent insider transactions involving Coeptis Therapeutics Holdings Inc (COEP) include a net purchase of 44,244 shares made by Gene Salkind , a net purchase of 25,054 shares made by David Mehalick , and a net purchase of 11,582 shares made by Chris Calise .
In summary, during the past 3 months, insiders sold 0 shares of Coeptis Therapeutics Holdings Inc (COEP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Coeptis Therapeutics Holdings Inc (COEP) were sold and 105,996 shares were bought by its insiders, resulting in a net purchase of 105,996 shares.
Coeptis Therapeutics Holdings Inc (COEP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Coeptis Therapeutics Holdings Inc Insider Transactions
Daniel Alexander Yerace Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Alexander Yerace. You might contact Daniel Alexander Yerace via mailing address: 402 Schomburg Court, Cranberry Township Pa 16066.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
